rs777848503

Variant summary

Our verdict is Pathogenic.
+13 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 13 classification points (ACMG Germline Pathogenicity v2019). PVS1_ModeratePS1PS4_SupportingPM2PP5_Strong

The NM_000038.6(APC):c.646-2A>C variant causes a splice acceptor change involving the alteration of a non-conserved nucleotide. This is a canonical splice-site variant (loss-of-function). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

APC
NM_000038.6 splice_acceptor

Predictors

6
1
AlphaGenome AVI: 31 : Pathogenic
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 6.46

Publications

0 publications found
Genes affected
APC (HGNC:583): (APC regulator of Wnt signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000038.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 13 points.

PVS1Null variant in LOF gene
Non-NMD splice frameshift: disease mechanism, small exon — moderate (PVS1 downgraded to PM); Splice acceptor variant predicted to cause a frameshift; NMD not predicted. Loss of function is a known disease mechanism, but the exon is small
PS1Same amino acid change as known pathogenic
Splice site has a more-destructive ClinVar pathogenic — strong (PS1); A more pathogenic splice-site variant at the same position has been reported in ClinVar.
PS4Prevalence increased in affected individuals
Rare variant reported in affected individuals by ≥2 independent ClinVar submitters (PS4_Supporting); 2 ClinVar submitter(s) report the variant in affected individuals; SCV003525929: Disruption of this splice site has been observed in individual(s) with familial adenomatous polyposis (PMID: 12702169).; SCV005033883: This variant has been observed in individuals with a personal and/or family history that is consistent with APC-associated disease (Personal communication; Heinritz W et al. Clin Genet, 2003 Apr;63:325-7; Lee JK et al. Cancer Genet, 2022 Apr;262-263:95-101). Other alterations impacting the same acceptor site (c.646-2A>G, c.646-1G>A) have been described in individuals with a personal history that is consistent with APC-associated disease (van der Luijt et al. Hum Mutat. 1997;9(1):7-16; Lagarde A et al. J. Med. Genet. 2010 Oct;47:721-2; Crobach S et al. Fam. Cancer 2012 Dec; Tsukanov AS et al. Russian Journal of Genetics, 2017;53(3):369-75; Ambry internal data).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00124) — PM2 moderate
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000038.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

APC NM_000038.6
MANE Select
HGVSc / HGVSpc.646-2A>C
Exon rankIntron 6 of 15
splice_acceptor
Prot: NP_000029.2
APC NM_001407446.1
HGVSc / HGVSpc.676-2A>C
Exon rankIntron 5 of 15
splice_acceptor
Prot: NP_001394375.1
APC NM_001354896.2
HGVSc / HGVSpc.646-2A>C
Exon rankIntron 6 of 16
splice_acceptor
Prot: NP_001341825.1

Ensembl Transcripts

APC ENST00000257430.9
MANE Select
HGVSc / HGVSpc.646-2A>C
Exon rankIntron 6 of 15
splice_acceptor
Prot: ENSP00000257430
APC ENST00000508376.7
TSL:1
HGVSc / HGVSpc.646-2A>C
Exon rankIntron 7 of 16
splice_acceptor
Prot: ENSP00000427089
APC ENST00000508624.5
TSL:1
HGVSc / HGVSpc.646-2A>C
Exon rankIntron 6 of 16
splice_acceptorNMD_transcript
Prot: ENSP00000424265

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:29
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Familial adenomatous polyposis 1 (3)
1
-
-
Hereditary cancer-predisposing syndrome (1)

Computational Scores

AlphaGenome AVI
Pathogenic31
BayesDel_addAF
Pathogenic0.63D
BayesDel_noAF
Pathogenic0.19
CADD
Pathogenic35
DANN
Uncertain0.99
Eigen
Pathogenic1.1
Eigen_PC
Pathogenic0.91
FATHMM_MKL
Pathogenic0.98D
GPN-Star LLR
N/A-11
GPN-Star score
N/A11
Mutation Taster
N/A2/98disease causing
PhyloP100
Uncertain6.5
Showing 12 of 12 scores

Splicing Scores

dbscSNV1_ADA
Pathogenic1.0
dbscSNV1_RF
Pathogenic0.93
DS_AG_spliceai
Pathogenic0.86
Position offset: 12
DS_AL_spliceai
Pathogenic1.0
Position offset: 2
Pangolin (max)
Pathogenic0.87
Pangolin gain
Pathogenic0.77
Position offset: 7
Pangolin loss
Pathogenic0.87
Position offset: 2
SpliceAI score (max)
Pathogenic1.0
Details are displayed if max score is > 0.2
Showing 8 of 8 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.